Pozen Sues Teva Over Migraine Drug ANDA
Pharmaceutical company Pozen Inc. has sued Teva Pharmaceuticals USA Inc., alleging Teva infringed two patents by seeking regulatory approval of a generic version of the migraine treatment Treximet....To view the full article, register now.
Already a subscriber? Click here to view full article